Algernon Health Inc.
AGN
CNSX
| 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -11.72% | -29.46% | -44.68% | -42.15% | -58.31% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -33.29% | -45.67% | -57.67% | -42.36% | -54.49% |
| Operating Income | 33.29% | 45.67% | 57.67% | 42.36% | 54.49% |
| Income Before Tax | -225.82% | 35.90% | 105.57% | 93.25% | 92.52% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -225.82% | 35.90% | 105.57% | 93.25% | 92.52% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -225.82% | 35.90% | 105.57% | 93.25% | 92.52% |
| EBIT | 33.29% | 45.67% | 57.67% | 42.36% | 54.49% |
| EBITDA | 34.86% | 45.88% | 57.81% | 42.30% | 54.56% |
| EPS Basic | -51.62% | 38.83% | 107.88% | 94.72% | 92.71% |
| Normalized Basic EPS | 54.18% | 54.35% | 70.12% | 64.58% | 73.14% |
| EPS Diluted | -30.03% | 42.63% | 105.57% | 92.95% | 91.51% |
| Normalized Diluted EPS | 54.18% | 54.35% | 70.12% | 64.58% | 73.14% |
| Average Basic Shares Outstanding | 47.12% | 22.86% | 30.52% | 37.18% | 32.34% |
| Average Diluted Shares Outstanding | 47.12% | 22.86% | 30.52% | 37.18% | 32.34% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |